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Background. The neurobiological underpinnings of avolition in schizophrenia remain unclear. Most brain imaging re-
search has focused on reward prediction deﬁcit and on ventral striatum dysfunction, but ﬁndings are not consistent. In
the light of accumulating evidence that both ventral striatum and dorsal caudate play a key role in motivation, we inves-
tigated ventral striatum and dorsal caudate activation during processing of reward or loss in patients with schizophrenia.
Method. We used functional magnetic resonance imaging to study brain activation during a Monetary Incentive Delay
task in patients with schizophrenia, treated with second-generation antipsychotics only, and in healthy controls (HC).
We also assessed the relationships of ventral striatum and dorsal caudate activation with measures of hedonic experience
and motivation.
Results. The whole patient group had lower motivation but comparable hedonic experience and striatal activation than
HC. Patients with high avolition scores showed lower dorsal caudate activation than both HC and patients with low
avolition scores. A lower dorsal caudate activation was also observed in patients with deﬁcit schizophrenia compared
to HC and patients with non-deﬁcit schizophrenia. Dorsal caudate activity during reward anticipation was signiﬁcantly
associated with avolition, but not with anhedonia in the patient group.
Conclusions. These ﬁndings suggest that avolition in schizophrenia is linked to dorsal caudate hypoactivation.
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Introduction
Avolition, i.e. a deﬁcit of motivation, is highly preva-
lent in schizophrenia, being regarded as a key aspect
of the negative syndrome (Kirkpatrick et al. 2006;
Foussias et al. 2009; Strauss et al. 2013a). It can be
found already in the prodromal stage of the disorder,
and is often reported to be an important predictor of
poor outcome (Foussias et al. 2009; Strauss et al. 2013b).
Advances in cognitive and affective neuroscience have
informed the current conceptualizationofmotivationasa
multifaceted construct, including hedonic experience (i.e.
the ability to enjoy in-the-moment pleasant experience,
also referred toas ‘liking’), rewardprediction (i.e. the abil-
ity to motivate behavior to achieve an expected, but not
currently available pleasant experience), and other dis-
tinct elements, such as rewardvaluation, effort valuation,
encoding of action-outcome contingency, and decision-
making processes.
The activity of partially independent cortico-striatal
circuits seems to subtend different aspects of motiv-
ation, which should be regarded as separate, although
interrelated, components (Wallis, 2007; Barch & Dowd,
2010; Der-Avakian & Markou, 2012; Miller et al. 2014).
In fact, studies in healthy individuals have shown that
a brain network including the ventral striatum, orbito-
frontal cortex (OFC), insula, and medial prefrontal cor-
tex (mPFC) is involved in some aspects of motivation,
such as liking, reward anticipation, reward valuation,
and representation of stimulus-reward associations,
while a circuit including the dorsal caudate and
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dorsolateral prefrontal cortex (DLPFC) underlies other
aspects of motivation, such as encoding of action-out-
come contingency and representation of the expected re-
ward value of action (Berridge & Robinson, 2003;
Delgado et al. 2005; Haruno & Kawato, 2006; Balleine
et al. 2007; Wallis, 2007; Barch & Dowd, 2010; Haber &
Knutson, 2010). These different facets of motivation
have synergic functions in instrumental learning and
adaptive behavior (Dolan & Dayan, 2013).
Current research suggests that persons with schizo-
phrenia have intact in-the-moment hedonic experience
(liking), but show abnormalities in other facets of the
motivational system (Gard et al. 2007; Heerey &
Gold, 2007; Heerey et al. 2007; Waltz et al. 2007;
Kring & Moran, 2008; Barch & Dowd, 2010; Cohen &
Minor, 2010; Foussias & Remington, 2010; Simpson
et al. 2012; Mann et al. 2013; Strauss et al. 2013a).
Most brain imaging research has focused on reward
prediction deﬁcit, reporting that a ventral striatum dys-
function is the neurobiological substrate of that deﬁcit
in patients with schizophrenia treated with ﬁrst-
generation antipsychotics (FGAs) or unmedicated/
never medicated (Juckel et al. 2006a,b; Schlagenhauf
et al. 2009; Nielsen et al. 2012a). However, no deﬁcit
of ventral striatum activity during reward prediction
was found in patients treated with second-generation
antipsychotics (SGAs), despite the presence of avoli-
tion in the same patients (Juckel et al. 2006b;
Schlagenhauf et al. 2008; Walter et al. 2009; Nielsen
et al. 2012b). Furthermore, ventral striatum hypoactiva-
tion has been found to correlate not only with mea-
sures of avolition (Simon et al. 2010) or avolition plus
anhedonia (Waltz et al. 2010), but also with measures
of depression (Simon et al. 2010) or positive symptoms
(Nielsen et al. 2012a, b; Esslinger et al. 2012).
No study has focused as yet on the circuit involving
the dorsal caudate and the DLPFC during reward an-
ticipation in persons with schizophrenia, in spite of ac-
cumulating evidence that this circuit plays a key role in
motivation (Palmiter, 2008; Balleine & O’Doherty,
2010; Wang et al. 2013; Miller et al. 2014).
In the present functional magnetic resonance imaging
(fMRI) study, using theMonetary IncentiveDelay (MID)
task (Knutson et al. 2000), we investigated: (a) the acti-
vation of the ventral striatum and dorsal caudate during
anticipation of reward or loss in patients with schizo-
phrenia living in the community and stabilized on treat-
ment with SGAs only, (b) the relationships of ventral
striatum and dorsal caudate activation with hedonic ex-
perience and motivation, and (c) differences in striatal
activation of patientswith high and lowavolition scores,
as well as of patients with Deﬁcit Schizophrenia (DS),
characterized by primary and persistent negative symp-
toms, and Non-Deﬁcit schizophrenia (NDS) which
might have different reward sensitivity.
The study included chronic patients with schizo-
phrenia, as this population might have a full range of
persistent avolition severity, while showing attenuated
or remitted positive symptoms.
Method
Subjects
All outpatients with a DSM-IV diagnosis of schizo-
phrenia attending the outpatient unit of the Department
of Psychiatry of the University of Naples SUN between
September 2010 and July 2012 were screened for the
study. Diagnoses were conﬁrmed using the Mini
International Neuropsychiatric Interview-Plus (MINI-
Plus), a structured interview for DSM-IV and ICD-10 di-
agnosis used in research settings (Sheehan et al. 1998).
Additional eligibility criteria were: age between 18 and
65 years; no evidence of mental retardation; clinically
stable (i.e. no hospitalization or change in psychotropic
medication for 3 months prior to scanning), to avoid the
presence of severe positive symptoms which might
cause secondary negative symptoms; treatment with
SGAs only; no history of head trauma with loss of con-
sciousness; and no substance abuse or dependence in
the preceding 6 months (except for smoking).
Sex- and age-matched (±3 years) healthy controls
(HC) were recruited from the community via ﬂyers
and screened to exclude any lifetime personal history
of mental illness using the MINI-Plus. Additional eligi-
bility criteria were: no family history of mental illness
or psychiatric hospitalization; no past history of head
trauma with loss of consciousness; no lifetime history
of substance abuse or dependence (except for smok-
ing); not on prescribed medications that might affect
CNS functions.
The study was approved by the University Ethics
Committee, and all participants signed a written
informed consent.
Assessments
All subjects were interviewed to record socio-
demographic variables, including age, education and
socioeconomic status. An estimate of full-scale IQ
was obtained using the revised version of the
Wechsler Adult Intelligence Scale.
All participants completed the Temporal Experience
of Pleasure Scale (TEPS; Gard et al. 2006), an 18-item
self-report measure of anticipatory and consummatory
pleasure, with higher scores indicating greater experi-
ence of pleasure; and the Revised Physical Anhedonia
Scale (PAS; Chapman & Chapman, 1978), a 61-item
scale evaluating trait anhedonia, with higher scores
indicating greater anhedonia. Participants were also
administered the Quality of Life Scale (QLS; Heinrichs
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et al. 1984). According to Nakagami et al. (2010), real-life
motivation was computed as the average score on three
QLS items: Motivation (‘ability to sustain goal-directed
activities’), Curiosity (‘degree to which one is interested
in his/her surroundings’), and Sense of Purpose (‘re-
alistic integrated life goals’), with higher scores indicat-
ing greater motivation.
Patients were administered the Schedule for the
Deﬁcit Syndrome (SDS; Kirkpatrick et al. 1989),
through which avolition was assessed by summing
the scores on the items Curbing of Interests,
Diminished Sense of Purpose, and Diminished Social
Drive, with higher scores indicating greater avolition
(Kirkpatrick et al. 1989; Kimhy et al. 2006; Galderisi
et al. 2013); and the Positive and Negative Syndrome
Scale (PANSS; Kay et al. 1987) to assess positive symp-
toms and depression. The daily antipsychotic dose on
the day of scanning was converted to chlorpromazine
equivalents following Gardner et al. (2010).
Experimental design
We used a modiﬁed version of the MID task (Knutson
et al. 2000) including 96 trials, each lasting 8 s, with a
total task duration of 12 min. In this task, the subject
has to press a button within a predeﬁned time window
to win or avoid losing money. There were four incen-
tive conditions (18 trials each) – large reward, small
reward, large loss, and small loss – and a neutral con-
dition (24 trials), presented in a random order and indi-
cated by a different cue (online Supplementary
Fig. S1). The number of trials was chosen according
to the original MID task studies (Knutson et al. 2000,
2001a, b) and several other studies carried out in
patients with schizophrenia (Juckel et al. 2006a, b;
Schlagenhauf et al. 2008). All these studies were able
to demonstrate signiﬁcant incentive effects in relatively
small groups (about 10 subjects per group).
During each trial, participants were presented with
one of the cues for 250 ms, followed by a ﬁxation
cross for 2000–2500 ms, and then by a white target
for 160–360 ms. Subjects either gained or avoided los-
ing money by pressing a button during the short target
presentation time window. A feedback followed for
1650 ms, with the amount of money gained or lost in
the trial and the cumulative outcome. The inter-trial in-
terval was jittered between 3240 and 3940 ms to keep
constant the trial duration (8 s).
The task difﬁculty was personalized during a prac-
tice session prior to scanning according to the original
MID task design (Knutson et al. 2001a, b) to allow at
least 66% of success. Task individualization was
aimed to make the task difﬁculty comparable across
subjects but not to oversimplify the task for patients.
Patients were slower and target exposure was longer
but the difﬁculty was set at the same level for patients
and controls. In fact, target offset was individually de-
termined based on the reaction time recorded during
the practice session, so that each subject experienced
difﬁculties in hitting the button in time before target
offset in about 33% of the trials. The post-training tar-
get offset varied from 140 to 530 ms (92.9% of patients
and 100% of HC were in a range from 166 to 450).
Subjects viewed the stimuli, projected onto a back-
illuminated translucent screen, through a mirror at-
tached to the head coil. They were instructed to press
the button as fast as possible irrespective of the cue
type. After the scan, participants were paid the amount
of money they won.
Smokers were allowed to smoke prior to MRI scan-
ning (last cigarette approximately 60 min before
session) to avoid the potential effects of nicotine
withdrawal.
MRI acquisition parameters
Structural and functional images were acquired on a
3.0-T scanner (Philips, Achieva, The Netherlands),
equipped with a standard radio-frequency head coil.
Head movements were restricted using foam cushions.
Structural images were acquired via a high resolution,
T1-weighted 3D MPRAGE sequence (TR = 7.1 ms; TE =
3.2 ms; ﬂip angle = 9°; voxel = 1 × 1 × 1 mm). T2*-
weighted functional images covering the whole brain
were acquired using a GRE-EPI sequence depicting
an event-related blood oxygen-level dependent
(BOLD ) signal (TR = 2000 ms; TE = 40 ms; thickness =
4 mm; matrix size = 128 × 128; FOV = 230 mm; voxel =
3.59 mm2), providing 32 interleaved images per
volume, parallel to the AC–PC line and covering the
whole brain. Each fMRI series consisted of 368 images,
the ﬁrst four of which were discarded to allow the
scanner to reach a steady state.
Image processing
For image preprocessing and GLM analysis, the
SPM8 software package (Wellcome Trust Centre for
Neuroimaging, London, UK; http://www.ﬁl.ion.ucl.
ac.uk) was used. Preprocessed images were corrected
for differences in slice-time acquisition, realigned to
the mean volume, and spatially normalized to the stan-
dard template of the Montreal Neurological Institute
(MNI). The spatially normalized data were smoothed
with an isotropic Gaussian ﬁlter (6 mm full-width half-
maximum) to compensate for normal variation across
subjects.
For each subject, data were modeled with a general
linear model, with six movement parameters as nuis-
ance regressors. Vectors of onset representing large re-
ward, small reward, large loss, small loss, and neutral
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condition were convolved with a canonical hemody-
namic response function. Contrast images of BOLD ac-
tivity associated with incentive compared to neutral
trials were produced for each participant.
Whole brain random-effects statistical maps were
thresholded at p < 0.001, with an extent threshold of
10 voxels, uncorrected for multiple comparisons.
False discovery rate (FDR) corrections for multiple
comparisons were performed on all results, except
for the ventral striatum and dorsal caudate, for
which small volume statistics were applied, for
which a family-wise error (FWE) peak correction was
deemed appropriate, as these are considered appropri-
ate for small structures, where a relatively small num-
ber of voxels per cluster is to be expected (Walter et al.
2009). Predeﬁned volumes of interest (VOIs) for these
structures were derived from key relevant publica-
tions. The MNI coordinates for the ventral striatum
(x = ±9, y = 5, z =−2) were deﬁned according to a recent
study by Nielsen et al. (2012b). For the dorsal caudate
(x = ±15, y = 8, z = 22), the coordinates were set accord-
ing to Robinson et al. (2012), based on connectivity pat-
terns. In each participant, VOIs were deﬁned as cubes
measuring 10 × 10 × 10 mm centered on the above coor-
dinates. The shape and dimension of the region of
interest were adopted from Nielsen et al. (2012a, b)
who investigated ventral striatal activation in patients
with schizophrenia and its associations with psycho-
pathology. Online Supplementary Fig. S2 illustrates
the VOI boundaries.
For correlations, measures of brain activation (mean
parameter estimates within a VOI with equal weights
for all voxels) for each contrast were extracted from
the above VOIs as well as from VOIs of key cortical
regions connected with ventral striatum and dorsal cau-
date, namely OFC and DLPFC, using the MARSBAR
toolbox (http://marsbar.sourceforge.net).
Statistical analyses
Group differences in sex distribution were assessed by
the Pearson’s χ2 test. Analysis of variance (ANOVA)
was used to test group differences on continuous
variables.
Relationships of measures of brain activation in the
ventral striatum, dorsal caudate, OFC and DLPFC
with anhedonia, motivation and avolition were
examined in patients using Pearson’s correlation coefﬁ-
cients. Intercorrelations between anhedonia and avoli-
tion/motivation measures were examined to verify
whether these were distinct constructs or measured
partially overlapping constructs. Differences in the cor-
relation pattern between striatal VOIs (dorsal caudate
and ventral striatum) or connected VOIs (DLPFC and
OFC, respectively) were examined using Steiger’s Z
test, if at least one correlation with the scores for motiv-
ation/avolition or anhedonia was signiﬁcant. Since
multiple correlations were computed between VOIs
and the above scores, a Bonferroni correction for mul-
tiple test was applied and will be reported; however,
since Bonferroni correction can bias results toward
type-2 statistical error, particularly for a relatively
small sample size, and given our a priori hypothesis
of the direction of the correlations (negative for avoli-
tion or anhedonia, and positive for motivation), only
Bonferroni correction for one-tailed alpha = 0.05 will
be reported (Bonferroni-corrected p = 0.008). Since anti-
psychotic treatment, depression severity and positive
symptoms might inﬂuence striatal activity, anhedonia
and motivation, correlations between these variables
were examined using partial correlation analyses con-
trolling for daily antipsychotic dose, positive symp-
toms scores and depression scores.
Results
Subject characteristics
Twenty-eight patients with schizophrenia and 22 HC
completed the study. There was no group difference
in sex, age, parental education, socioeconomic status
or proportion of habitual cigarette smokers (Table 1).
No current Axis I disorder other than schizophrenia
was present in patients; a lifetime diagnosis of major
depression, single episode, was present in only one
patient, while a lifetime anxiety disorder was present
in two patients (in one case panic disorder without
agoraphobia and in the other obsessive compulsive
disorder). Patients had signiﬁcantly lower IQ and edu-
cation than controls (Table 1). Since these variables can
affect both performance on the MID task and subjects’
ability to report their experience on self-administered
scales, education and IQ were entered as covariates
in group comparisons on these measures and fMRI
contrasts. There was no group difference in trait anhe-
donia as evaluated by the PAS, or anticipatory and
consummatory experience of pleasure as assessed by
the TEPS. Patients had signiﬁcantly lower real-life mo-
tivation than controls. In the latter group, 18 out of 22
subjects had the maximum score of 6 and the remain-
ing individuals had a score of 5, with a clear ceiling ef-
fect; among patients, two out of 28 reached the score of
6 and only ﬁve had a score of 5.
MID task performance
Details of MID task performance are shown in online
Supplementary Table S1. For reaction time, a main ef-
fect of the cue was found in controls only (F4,84 = 8.12,
p < 0.00001), due to the fact that they were faster
for small reward (p < 0.002) and large reward
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(p < 0.00001) than for neutral cues. Patients did not
show a signiﬁcant effect of the cue (F4,108 = 0.84, p =
0.49). There was no main effect of diagnosis (F1,46 =
1.20, p = 0.28) and no cue × diagnosis interaction
(F4,184 = 1.05, p = 0.39).
As expected, due to the personalized duration of the
target presentation, there was no group difference in
the number of successful trials and there was no
signiﬁcant cue × diagnosis interaction on the same
measure. Accordingly, there was no group difference
in the average monetary gain during the task.
Since therewas no signiﬁcant difference in behavioral
data between large and small incentive cues, large and
small reward trials were collapsed into a single reward
condition, and large and small loss trials were collapsed
into a single loss condition in all fMRI comparisons.
fMRI results
Anticipation of reward or loss v. neutral
For the contrast anticipation of the reward v. neutral
condition, both patients and controls showed an acti-
vation in the ventral striatum, which was signiﬁcant
only on the right side in controls and on both sides in
patients (Table 2 and Fig. 1). The dorsal caudate was
signiﬁcantly activated bilaterally in controls, but
showed no activation in patients (Table 2 and Fig. 1).
The key cortical regions involved in reward processing
were also active in both groups, namely the OFC (BA
47, Table 2) and the DLPFC (BA 9/46, Table 2). As
reported in Table 2, controls showed an activation of
the right hippocampus and parahippocampal gyrus
(BA 36), visual areas and cerebellum, while patients pre-
sented an activation in a larger number of cortical areas,
including visual and cerebellar areas, right insula and
temporal pole (BA 13/38) adjacent to the OFC, right an-
terior cingulate (BA 24/23), left inferior frontal (BA 44/
45), as well as parietal areas (BA 43 and BA 7).
However, no signiﬁcant between-group difference for
any of these regions was observed for that contrast.
For the contrast anticipation of the loss v. neutral
condition, the ventral striatum was not active in either
group. The dorsal caudate was signiﬁcantly activated
bilaterally in controls, but showed no activation in
patients (Table 3, Fig. 1). The DLPFC was activated
in both groups, while the OFC and temporal pole
were activated only in patients (Table 3, Fig. 1). In con-
trols, for the same contrast, a signiﬁcant activation was
also observed in the hippocampus and in visual areas
(Table 3). For the same contrast in patients, an acti-
vation was also found in right associative temporal
areas (BA 39), cerebellum and visual areas. However,
Table 1. Study sample: descriptive information
HCs (N = 22) SCZ (N = 28) F/χ2 df p
Demographic information
Sex (M/F) 10/12 18/10 1.77 1 0.18
Age, years 31.91 ± 8.49 33.10 ± 6.67 0.29 1.48 0.59
Education, years 16.04 ± 2.69 12.43 ± 3.33 17.4 1.48 0.00001
Paternal education 11.16 ± 4.99 10.20 ± 5.09 0.16 1.48 0.69
Maternal education 10.00 ± 5.19 9.93 ± 4.94
Socioeconomic status 35.71 ± 11.12 33.24 ± 14.03 0.44 1.46 0.51
General cognitive abilities
WAIS-R Full-scale IQ 113.76 ± 15.23 79.35 ± 18.23 53.8 1.48 0.000001
Real-life motivation and anhedonia
Real-life motivation 5.79 ± 0.36 3.16 ± 1.65 9.54 1.45 0.005
TEPS consummatory pleasure 4.84 ± 0.61 4.15 ± 0.81 0.23 1.43 0.63
TEPS anticipatory pleasure 4.58 ± 0.53 3.95 ± 0.63
PAS total score 17.14 ± 6.32 23.80 ± 8.07 0.46 1.43 0.50
Clinical information
PANSS Positive 8.04 ± 4.13
PANSS Negative 11.64 ± 6.87
PANSS Disorganization 7.11 ± 2.56
PANSS Depression 2.53 ± 0.67
SDS Avolition 4.64 ± 3.29
HCs, Healthy controls; SCZ, subjects with schizophrenia; WAIS-R, Wechsler Adult Intelligence Scale – Revised; IQ,
Intelligence Quotient; TEPS, Temporal Experience of Pleasure Scale; PAS, Revised Physical Anhedonia Scale; PANSS, Positive
and Negative Syndrome Scale; SDS, Schedule for the Deﬁcit Syndrome; Real-life motivation: average score on the Motivation,
Curiosity and Sense of Purpose items of the Quality of Life Scale
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no signiﬁcant between-group difference for any of
these regions was observed for that contrast.
Feedback processing
Bothpatients andcontrols showedasigniﬁcantactivation
of the ventral striatumduring reward v. neutral feedback,
whichwas signiﬁcant only on the left side in patients and
on both sides in controls (Table 4). Both groups activated
the right OFC (BA 47), the key cortical region involved in
reward valuation, and the adjacent right temporal pole
(BA 38), functionally connected to the insula and OFC.
Patients also activated the anterior insula (BA 13) bilater-
ally. Both groups activated themPFC (BA 32) and the ad-
jacent anterior cingulate (BA 24). Both groups activated
right cerebellum and postcentral (BA 43) areas.
No between-group difference was observed for any
of these regions.
Correlations
Correlations between anhedonia and avolition were
modest and not statistically signiﬁcant (r = 0.38, p =
0.06) and the same was true for anhedonia and motiv-
ation (r =−0.29, p = 0.16). Furthermore, avolition and
motivation scores were not correlated with TEPS
score for anticipatory pleasure (r =−0.18, p = 0.387
and r = 0.19, p = 0.375, respectively). These results indi-
cated that the constructs of anhedonia and avolition
are at least partially independent and that avolition
and motivation do not derive from a deﬁcit in the abil-
ity to anticipate pleasure. On the other hand, avolition
was signiﬁcantly correlated to motivation in the real
world (r =−0.66, p < 0.0001). This latter correlation
indicates that avolition and motivation are intercorre-
lated constructs.
For the ventral striatum activity during anticipation,
no signiﬁcant correlation with anhedonia, motivation
and avolition was found in patients. For the dorsal
caudate activity during anticipation for the contrast
reward v. neutral, a positive correlation (online
Supplementary Fig. S3) was found with real-life motiv-
ation (r = 0.53, p < 0.006 for the left side; r = 0.61, p <
0.001 for the right side), and a negative correlation
(online Supplementary Fig. S3) was observed with
Table 2. Functional magnetic resonance imaging activations during anticipation of reward v. neutral
Healthy controls Subjects with schizophrenia
Peak t test
value
Talairach coordinates
Peak t test
value
Talairach coordinates
BA x y z x y z
Right ventral striatum 5.38a 9 2 −4 4.01a 12 8 1
Left ventral striatum 4.91a −12 2 1
Right dorsal caudate 6.00a 12 12 17
Left dorsal caudate 6.35a −12 6 20
Right orbitofrontal cortex 47 3.92 53 19 −8 6.61 33 19 −8
Right temporal pole 38 5.20 45 19 −15 6.33 48 16 −15
Right dorsolateral prefrontal cortex 46 5.27 50 43 7 5.87 45 37 7
Right dorsolateral prefrontal cortex 9 4.57 48 9 25 5.64 53 21 25
Right insula 13 5.83 42 −1 −4
Right anterior cingulate gyrus 24 6.11 3 0 26
Right anterior cingulate gyrus 23 5.73 0 −29 30
Right hippocampus 8.21 27 −36 3
Right parahippocampal gyrus 36 5.48 39 −31 −10
Left inferior frontal gyrus 44 6.38 −45 12 20
Left inferior frontal gyrus 45 4.88 −42 20 14
Left precuneus/cuneus 19/18 9.88 −24 −100 −2 7.75 −30 −69 35
Right cerebellum declive 9.32 27 −80 −13 7.49 27 −66 −21
Right cerebellum culmen 6.25 3 −40 −22
Left inferior parietal lobule 40 6.79 −48 −42 45
Right superior parietal lobule 7 7.72 27 −66 46
BA, Brodmann area.
Brain activation during anticipation of reward. All results are signiﬁcant at p < 0.05, false discovery rate corrected for
multiple comparisons except when otherwise speciﬁed.
a Signiﬁcant family-wise error corrected for small volume.
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Fig. 1. Mean blood oxygen level-dependent activity for the contrasts (a) reward v. neutral anticipation and (b) loss v. neutral
anticipation in ventral striatum (VS, upper row, Talairach coordinates x = 9, y = 5, z =−2) and dorsal caudate (DC, middle and
bottom rows, Talairach coordinates x = 15, y = 9, z = 20) in healthy controls (right sections) or subjects with schizophrenia (left
sections). For illustrative purposes, maps were thresholded at p < 0.001, with an extent threshold of 10 voxels. Left is on the
left (neurological convention).
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Table 3. Functional magnetic resonance imaging activations during anticipation of loss v. neutral
Healthy controls Subjects with schizophrenia
BA
Peak t test
value
Talairach coordinates
Peak t test
value
Talairach coordinates
x y z x y z
Right dorsal caudate 4.44a 12 12 17
Right dorsal caudate 4.60a −12 6 20
Right dorsolateral prefrontal cortex 46 4.93 50 32 16 5.60 48 38 13
Right dorsolateral prefrontal cortex 46 4.74 50 43 7 5.04 42 15 20
Right dorsolateral prefrontal cortex 9 5.12 39 6 25
Right orbitofrontal cortex 47 4.87 39 22 −5
Left orbitofrontal cortex 47 4.95 −33 16 −5
Left orbitofrontal cortex 47 4.50 −24 22 −10
Right temporal pole 38 9.15 48 16 −18
Right middle temporal gyrus 21 6.54 59 −45 −2
Right middle temporal gyrus 39 5.77 30 −55 26
Right occipital gyrus 19 6.24 24 −100 6 5.62 33 −76 24
Left precuneus/cuneus 19/18 7.00 −24 −97 1 5.59 −27 −75 30
Left superior occipital gyrus 19 4.77 −30 −81 24
Right cerebellar vermis 5.90 30 −63 −21
Right cerebellar vermis 4.77 30 −52 −22
Left cerebellar vermis 5.54 −18 −72 −18
BA, Brodmann area.
Brain activation during anticipation of loss. All results are signiﬁcant at p < 0.05, false discovery rate corrected for multiple
comparisons except when otherwise speciﬁed.
a Signiﬁcant family-wise error corrected for small volume.
Table 4. Functional magnetic resonance imaging activations during feedback evaluation
Reward v. neutral feedback
Healthy controls Subjects with schizophrenia
Peak t test
Talairach coordinates
Peak t test
Talairach coordinates
BA value x y z value x y z
Right ventral striatum 4.09a 12 5 1
Left ventral striatum 4.87a −12 2 1 4.22a −12 2 1
Left mesial prefrontal cortex 32 5.85 0 15 28 5.73 −3 9 34
Left anterior cingulate 24 6.81 −6 −5 34 5.10 0 18 36
Right orbitofrontal cortex 47 9.04 39 16 −3 4.64 39 14 −4
Right temporal pole 38 7.61 50 10 −10 4.46 56 13 −8
Right insula 13 5.63 39 −1 6
Left insula 13 8.65 −39 −1 1
Right cerebellar vermis 7.08 15 −55 −39 7.33 6 −61 −26
Left cerebellar vermis 5.96 0 −64 −36
Right postcentral gyrus 43 6.59 62 −17 21 6.53 62 −18 16
BA, Brodmann area.
Brain activation during reward feedback. All results are signiﬁcant at p < 0.05, false discovery rate corrected for multiple
comparisons except when otherwise speciﬁed.
a Signiﬁcant family-wise error corrected for small volume.
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avolition (r =−0.50, p < 0.007 for the left side; r =−0.46,
p < 0.01 for the right side; the latter did not survive
Bonferroni correction). The correlation between the
left dorsal caudate and avolition remained signiﬁcant
after controlling for the effects of PANSS depression
and positive symptoms factors, as well as chlorproma-
zine equivalent dose (r =−0.53; p < 0.008).
Differences in the association of avolition/motivation
with activity of the dorsal caudate or ventral striatum
for the contrast reward v. neutral were tested using
the Steiger test for dependent correlations and found
to be statistically signiﬁcant (Z =−1.98, n = 28, p < 0.05
for the correlations of avolition with left dorsal caudate
and left ventral striatum; Z = 2.01, n = 27, p < 0.04 for the
correlations of motivation with left dorsal caudate and
left ventral striatum; Z = 2.81, n = 27, p < 0.005 for the
correlations of motivation with right dorsal caudate
and right ventral striatum.)
For the dorsal caudate activity during anticipation for
the contrast loss v. neutral, no signiﬁcant correlation
was found with anhedonia, motivation and avolition.
No signiﬁcant correlation was observed for the feed-
back analyses.
Comparisons of high- v. low-avolition subjects
A median split analysis was carried out to compare
patients with high v. low avolition scores on ventral
striatum and dorsal caudate activation and on demo-
graphic, psychometric and clinical variables.
High- and low-avolition subgroups did not differ on
age (F1,26 = 0.71, p = 0.41), education (F1,26 = 0.46, p =
0.51) and IQ (F1,26 = 3.43, p = 0.08). The high-avolition
group, in comparison with the low-avolition group,
was receiving a higher chlorpromazine equivalent
dose of antipsychotic (F1,22 = 4.94, p = 0.04). The chlor-
promazine equivalent dose was entered as covariate
when the two subgroups were compared on striatal
activity. No difference was found between the two
subgroups with respect to the scores on PANSS de-
pression and positive symptom factors, TEPS and
PAS. Real-life motivation was signiﬁcantly lower in
high- v. low-avolition patients (F1,24 = 9.55, p < 0.005).
ANCOVA on the ventral striatum activity (reward v.
neutral condition) with group (DS, NDS, HC) as be-
tween factor and education and IQ as covariates did
not show any signiﬁcant main effect of group (F2,43 =
0.55, p = 0.58); the same analysis on the left dorsal cau-
date activity yielded a signiﬁcant group effect (F2,43 =
2.83, p < 0.05) and Bonferroni post-hoc test revealed a
signiﬁcantly reduced activity only in the high-avolition
subgroup v. HC (online Supplementary Fig. S4).
Comparison between the high- and low-avolition
subgroups, with chlorpromazine equivalent dose as
covariate, on the ventral striatum activity (reward v.
neutral condition) did not show any signiﬁcant main
effect of group (F1,25 = 0.001, p < 0.97); while the same
analysis on the left dorsal caudate activity yielded a
signiﬁcant group effect (F1,25 = 7.50, p < 0.03), due to
lower activity in the high-avolition subgroup (online
Supplementary Fig. S4).
Comparisons of DS v. NDS patients
Eleven patients were classiﬁed by the SDS as having
DS (i.e. their negative symptoms were primary and
persistent; avolition was one of the two or more nega-
tive symptoms justifying the diagnosis of DS in all 11
cases, and all of them were in the high-avolition
group) and 17 as having NDS (only 3/17 were in the
high-avolition group).
DS and NDS subgroups did not differ on age, edu-
cation, PANSS depression and positive symptom fac-
tors, TEPS and chlorpromazine equivalent dose of
antipsychotic. Compared with the NDS subgroup, DS
patients had signiﬁcantly lower IQ (F1,26 = 9.96, p <
0.004), higher PAS (F1,23 = 15.08, p < 0.0008) scores
and, as expected, higher avolition (F1,23 = 46.12, p <
0.000001) and lower motivation (F1,23 = 23.65, p <
0.00007) scores. IQ and PAS scores were entered as
covariate when comparing the two subgroups on
striatal activity.
ANCOVA on the ventral striatum activity (reward v.
neutral condition) with group (DS, NDS and HC) as
between factor and education and IQ as covariates
did not show any signiﬁcant main effect of group
(F2,43 = 0.63, p = 0.54). ANCOVA on the left dorsal cau-
date activity for the same contrast yielded a signiﬁcant
group effect (F2,43 = 2.65, p < 0.05); Bonferroni post-hoc
test revealed a signiﬁcantly reduced activity only in
the DS subgroup v. HC (online Supplementary
Fig. S5).
Comparison between the two subgroups of patients
on the ventral striatum activity for the same contrast,
with PAS scores and IQ as covariates, did not show a
signiﬁcant group effect (F1,24 = 3.14, p = 0.10) (online
Supplementary Fig. S5); while the same analysis on
the left dorsal caudate activity (for the same contrast
and with the same covariates) yielded a signiﬁcant
group effect (F1,24 = 3.59, p < 0.05), due to lower activity
in the DS subgroup (online Supplementary Fig. S5).
Discussion
The present study aimed to assess the role of ventral
striatum and dorsal caudate in motivation deﬁcits of
individuals with schizophrenia. To this aim, we inves-
tigated: (a) the activation of these two regions during
processing of reward or loss in persons with schizo-
phrenia living in the community and stabilized on
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treatment with SGAs only, and (b) the relationships of
ventral striatum and dorsal caudate activation with he-
donic experience and motivation.
Patients with schizophrenia did not differ from HC
with respect to their hedonic experience. This con-
clusion is based on the PAS and TEPS comparisons,
but also on ﬁndings concerning ventral striatum acti-
vation during reward feedback, that was observed in
both patients and controls, and was comparable be-
tween them. This is in line with previous reports of in-
tact in-the-moment ability to experience pleasure, in
the presence of impaired capacity to translate pleasur-
able experiences into motivational states, in schizo-
phrenia patients (see Strauss et al. 2013a for a
review). Our ﬁndings of preserved ventral striatal acti-
vation in patients with schizophrenia stabilized on
SGAs are in line with several previous studies
(Schlagenhauf et al. 2008; Walter et al. 2009; Simon
et al. 2010; Waltz et al. 2010; Nielsen et al. 2012a, b).
Some authors (Waltz et al. 2010) hypothesized that
the personalized performance in the MID task pro-
duced negative prediction errors (NPEs, i.e. more re-
ward than expected) more frequently than positive
prediction errors (PPEs, i.e. less reward than expected),
and response of the striatum to NPEs might be largely
intact in patients; however, in drug-naive subjects or in
those treated with FGAs, a deﬁcit of ventral striatal ac-
tivity was found using the same task. Other authors
speculated that SGAs might normalize at least in part
ventral striatal response, as demonstrated by longitudi-
nal studies, while FGAs do not (Juckel et al. 2006b;
Schlagenhauf et al. 2008; Walter et al. 2009; Nielsen
et al. 2012a, b). It has been hypothesized that sparing
of reward processing and ventral striatum response
observed with SGAs is related to their fast dissociation
from D2 receptors and low potential to induce extra-
pyramidal side-effects and depression, which might
cause secondary negative symptoms (Juckel et al.
2006a,b, Abler et al. 2008; Schlagenhauf et al. 2008;
Walter et al. 2009; Waltz et al. 2010; Nielsen et al.
2012a,b).
The hypothesis that a deﬁcit of reward anticipation
due to hypoactivation of the ventral striatum is respon-
sible for the motivation deﬁcit is not supported by our
ﬁndings. We found an activation of ventral striatum
and key cortical regions involved in reward antici-
pation in both patients and controls (including the
OFC, regarded as a key region in processing receipt
of monetary reward; Knutson et al. 2003) and no associ-
ation between the activation of these regions during re-
ward anticipation and measures of real-life motivation
or avolition. The discrepancy with previous studies
reporting an association between ventral striatal acti-
vation and avolition (also in the absence of a signiﬁcant
reduction of ventral striatal activation in patients
compared to controls) (e.g. Simon et al. 2010; Waltz
et al. 2010) might be explained by the use of different
measures of avolition, e.g. the sum of anhedonia and
avolition scores (Waltz et al. 2010) or differences in
the severity of anhedonia, which might contribute to
motivation deﬁcits through a reduced sensitivity to re-
ward (Simon et al. 2010). As a matter of fact, in the
study of Simon et al. (2010), patients differed from
HC in the severity of physical anhedonia, while our
patients did not differ on the same measure from con-
trols. The absence of signiﬁcant degrees of anhedonia
(as assessed with both the PAS and TEPS) in our
sample might also explain the lack of signiﬁcant
associations between anhedonia and ventral striatal ac-
tivation in our results.
The OFC, the key cortical region involved in reward
processing, in particular in reward value coding
(Peters & Büchel, 2010; Sescousse et al. 2010), was ac-
tive in both patients and controls, and this activation
did not show a signiﬁcant correlation with either
hedonic experience or motivation measures.
A deﬁcit of motivation may also reﬂect hypofunc-
tioning of the brain network including the dorsal cau-
date and DLPFC. In fact, an activation of the dorsal
caudate was found in studies in which subjects’ action
was essential for the outcome, such as those using the
MID task, in which the outcome depends on subjects’
speeded response (Delgado et al. 2000, 2004; Elliott
et al. 2000; Knutson et al. 2000, 2001a, b; Tricomi et al.
2004; Grahn et al. 2008), demonstrating that the dorsal
caudate is sensitive to action-outcome contingency,
rather than to rewards in themselves (Grahn et al.
2008). In addition, evidence has been provided by
neuroimaging and neuropsychological investigations
showing that the dorsal caudate is implicated in differ-
ent aspects of motivational processes with respect to
ventral striatum (Yin et al. 2006; Yin & Knowlton,
2006; Balleine et al. 2007). Recently, in healthy subjects,
the dorsal striatum was shown to be active when sub-
jects showed increased motivation, independent of re-
ward anticipation, while ventral striatum activation
was observed during reward anticipation only (Miller
et al. 2014).
The role of the DLPFC in decision-making based on
reward values and effort calculations, i.e. other aspects
of motivation, is also supported by several experimen-
tal ﬁndings (Miller & Cohen, 2001; Manes et al. 2002).
In our study, the dorsal caudate was signiﬁcantly
activated in controls for the anticipation of both reward
and loss, while in persons with schizophrenia it
showed no activation for either condition. The activity
of the dorsal caudate during reward anticipation was
signiﬁcantly associated with real-life motivation and
avolition, but not with anhedonia measures. A median
split analysis conﬁrmed the link between avolition and
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dorsal caudate hypoactivation in patients, as the dorsal
caudate activity was signiﬁcantly reduced in high-
avolition as compared to both HC and low-avolition
patients. No other assessed variable could explain the
ﬁnding, as the two subgroups of patients did not differ
for any demographic, psychometric or clinical vari-
ables, except chlorpromazine equivalents, that were
used as covariate in all comparisons between the two
groups of patients. Our analyses concerning DS and
NDS subgroups further corroborate the association of
dorsal caudate activity with avolition: all DS subjects
were in the high-avolition group while only 3/17 of
the NDS group were in the same group. DS patients,
characterized by a greater severity of avolition and
reduced motivation, had a reduced dorsal caudate ac-
tivity for the contrast reward v. neutral v. both HC and
NDS subjects. Furthermore, DS patients had compar-
able activation of the ventral striatum for the contrast
reward v. neutral with respect to both HC and NDS
subjects. The higher social anhedonia and lower IQ
of DS v. NDS were used as covariates and could not ac-
count for the reduced dorsal caudate activity.
In line with a report showing an inverse association
of the activity of the dorsal striatum, but not of the
DLPFC, with negative symptom severity in schizo-
phrenia patients (Ehrlich et al. 2012), we found no
deﬁcit in the activation of DLPFC and no association
between the degree of its activation and the severity
of motivation deﬁcits in our patients. As the activity
of this region underlies speciﬁc aspects of reward pro-
cessing, i.e. the ability to generate and execute goal-
directed action plans necessary to achieve a valued
outcome, our ﬁndings suggest that this aspect of re-
ward processing may not be the one primarily affected
in motivational deﬁcits of patients with schizophrenia
stabilized on treatment with SGAs. This tentative con-
clusion is in line with ﬁndings from a meta-analysis of
fMRI studies in schizophrenia, in which Goghari et al.
(2010) reported that negative symptoms have no
consistent relationship with DLPFC activity, as well
as with previous structural MRI ﬁndings from our
group (Volpe et al. 2012) showing no association be-
tween DLPFC gray-matter volume and negative symp-
toms in schizophrenia subjects.
An activation of the right hippocampus and parahip-
pocampal gyrus was also observed in HC. Actually, the
input from these structures to the striatum is important
to integrate information related to reward processing
and memory (O’Donnell & Grace, 1995). Patients dem-
onstrated no activation in these regions, but activated
a larger number of cortical areas, which might reﬂect
an attempt to overcome the hypoactivity of the dorsal
caudate and connected regions, such as the hippocam-
pus, and achieve normal performance through the in-
volvement of alternative circuits.
The main strengths of the present study include the
selection of patients with schizophrenia treated with
SGAs only, the use of speciﬁc instruments for the inde-
pendent assessment of motivation and hedonic experi-
ence, the assessment of different aspects of reward
processing, and the focus on both the ventral striatum
and the dorsal caudate.
As to limitations, the possibility that low IQ in some
of our patients represented a confounding factor can-
not be entirely ruled out. However, it is unlikely that
learning deﬁcits or other cognitive impairments con-
tributed to our ﬁndings. Indeed, IQ was used as a cov-
ariate in data analyses; the task was overly simple and
did not imply learning (subjects practiced the task in
advance); and task difﬁculty was personalized for
each participant, so that they could succeed on at
least 66% of the trials.
Treatment of patients with antipsychotic drugs
might represent a further limitation, as in the patient
group the lack of dorsal striatum activation during re-
ward anticipation might be attributed to the treatment
with SGAs. However, antipsychotics would be
expected to dampen the response to reward in all sec-
tions of the striatum, since all of them receive dopa-
mine innervation, while we observed in our patients
a signiﬁcant activation of the ventral striatum during
reward anticipation, a pattern similar to that observed
in healthy subjects. These results argue against a role of
SGAs in our ﬁndings.
Another limitation is the assessment of extrapyramidal
symptoms only during the routine neurological examin-
ationofourpatients,withoutusinga standardized instru-
ment. Extrapyramidal symptomsmight cause secondary
negative symptoms which might confound results con-
cerning avolition. However, we think it is unlikely that
extrapyramidal symptoms affected our ﬁndings concern-
ing avolition. First, subjects with primary and persistent
negative symptoms (deﬁcit schizophrenia), identiﬁed
using the SDS, were the majority of the subjects with
high avolition and, by deﬁnition, the inﬂuence of extra-
pyramidal symptoms on avolition in this group had to
be excluded. Second, our subjects had a preservedventral
striatal response to reward, that would be unlikely in the
presence of extrapyramidal side-effects.
Finally, to measure real-life motivation, we used an
index derived from the QLS scale, and healthy subjects
showed a ceiling effect on this instrument, preventing
the exploration of correlations between motivation
and striatal activation in this group.
In conclusion, our ﬁndings support the notion that
hedonic and motivational aspects of reward are sub-
tended by different subdivisions of the striatum; that
avolition in schizophrenia emerges independently of
in-the-moment ability to experience pleasure, and
that it is not linked to a ventral striatum dysfunction
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(at least in patients treated with SGAs) but to the
hypoactivation of the dorsal caudate.
Our ﬁnding of a dorsal striatum hypoactivation in
patients with schizophrenia is of interest also in the
light of the recently documented role of the human
dorsal striatum in complex social tasks, such as social
interactions in situations requiring cooperation
(Rilling et al. 2002) or revenge (de Quervain et al.
2004), or acquisition of social reputations through
trial and error (King-Casas et al. 2005). A future chal-
lenge for research in schizophrenia might be to further
improve our understanding of the role of the dorsal
striatum in motivation, using various reward and
social interaction paradigms. Progress in this ﬁeld
might foster the development of innovative pharmaco-
logical and rehabilitation treatments for schizophrenia.
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